Table 5.
Materials | Polyphenols | Drug Release | Target | Improvement | Ref. |
---|---|---|---|---|---|
Protein | Resveratrol | 65% at pH 7.4 (~72 h, high concentration) |
Caco-2 cancer cell | 97% cellular uptake after 24 h IC50 < 6% wt No toxicity to normal cell (100% wt) |
[81] |
Curcumin | 80% at pH 5 45% at pH 7.4 (~48 h) |
C6 glioma cell | Blood brain barrier penetration↑ (2-fold↑) Cancer proliferation and migration > 50%↓ |
[82] | |
At pH 7.4 ~53% (~8 h) ~94% (~72 h) |
HCT 116 cancer cell | Cellular uptake 2-fold↑ IC50 3.7 µg/mL (free curcumin is not toxic to 20 µg/mL) |
[83] | ||
Sustained~180 h ~66% at pH 5 ~49% at pH 7.4 |
MCF-7 breast cancer cell |
IC50 0.72 µg/mL (6-fold↓) Synergistic effect (CI > 1) |
[84] | ||
77% at pH 5.5 60% at pH 7.4 (~6 h) |
HeLa cell A549 cell |
IC50 6.5 µg/mL (35%↓) Cell surface attachment and localization |
[85] | ||
Iron ion | Curcumin | 91% at pH 5 34% at pH 7.4 (~24 h) |
MCF-7 human breast cancer cell |
Uptake efficiency 93% after 3 h Bcl-2 down-regulation (2.6-fold↓) Bax and caspase 3 up-regulation (40%↑) |
[90] |
Nucleic acid | Tannic acid | Disassembly in pH 5.5 | A549 human lung cancer cell |
Cellular uptake 7-fold↑ Apoptosis 40%↑ by tannic acid and 20%↑ by therapeutic genes |
[93] |
In acidic pH (when fused with endosomal/lysosomal vesicle) |
A549 human lung cancer cell |
Homotypic targeting (3-fold↑) Macrophage uptake 30%↓ Half-life 2.13 h (26-fold↑) Tumor growth 5-fold↓ |
[94] |
↑: Increase in some effects; ↓: Decrease in some effects.